Scotiabank analyst Ben Isaacson downgrades Braskem (NYSE:BAK) from Sector Perform to Sector Underperform.
Where Marinus Pharma Stands With Analysts
Analysts have provided the following ratings for Marinus Pharma (NASDAQ:MRNS) within the last quarter: Bullish Somewhat Bullish Indifferent…